Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy Lieberman

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Current Opinion in Immunology|September 23, 2003
Nuclear war: the granzyme A-bombJudy Lieberman, Zusen Fan
Current Opinion in Immunology|May 22, 2019
Granulysin: killer lymphocyte safeguard against microbesFarokh Dotiwala, Judy Lieberman
Nature Medicine|November 8, 2008
RIG-ing an antitumor responseFabio Petrocca, Judy Lieberman
Nature Reviews. Genetics|August 19, 2015
Knocking down disease: a progress report on siRNA therapeuticsAnders Wittrup, Judy Lieberman
Newsweek|December 27, 2005
Your health in the 21st century. Silencing bad genesAnthony Komaroff, Judy Lieberman
Advances in Immunology|May 30, 2009
Micromanagers of immune cell fate and functionFabio Petrocca, Judy Lieberman
RNA Biology|June 19, 2009
Micromanipulating cancer: microRNA-based therapeutics?Fabio Petrocca, Judy Lieberman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Promise and challenge of RNA interference-based therapy for cancerFabio Petrocca, Judy Lieberman
Cell Death and Differentiation|January 7, 2017
How ICE lights the pyroptosis fireXing Liu, Judy Lieberman
Nature Protocols|November 2, 2013
Production of highly potent recombinant siRNAs in Escherichia coliLinfeng Huang, Judy Lieberman
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Current Opinion in Immunology|September 23, 2003
Nuclear war: the granzyme A-bombJudy Lieberman, Zusen Fan
Current Opinion in Immunology|May 22, 2019
Granulysin: killer lymphocyte safeguard against microbesFarokh Dotiwala, Judy Lieberman
Nature Medicine|November 8, 2008
RIG-ing an antitumor responseFabio Petrocca, Judy Lieberman
Nature Reviews. Genetics|August 19, 2015
Knocking down disease: a progress report on siRNA therapeuticsAnders Wittrup, Judy Lieberman
Newsweek|December 27, 2005
Your health in the 21st century. Silencing bad genesAnthony Komaroff, Judy Lieberman
Advances in Immunology|May 30, 2009
Micromanagers of immune cell fate and functionFabio Petrocca, Judy Lieberman
RNA Biology|June 19, 2009
Micromanipulating cancer: microRNA-based therapeutics?Fabio Petrocca, Judy Lieberman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Promise and challenge of RNA interference-based therapy for cancerFabio Petrocca, Judy Lieberman
Cell Death and Differentiation|January 7, 2017
How ICE lights the pyroptosis fireXing Liu, Judy Lieberman
Nature Protocols|November 2, 2013
Production of highly potent recombinant siRNAs in Escherichia coliLinfeng Huang, Judy Lieberman
Pageof 22